tiprankstipranks
Advertisement
Advertisement
Biodexa Pharmaceuticals management to meet with Maxim
PremiumThe FlyBiodexa Pharmaceuticals management to meet with Maxim
23d ago
Biodexa Pharmaceuticals Announces Reverse ADR Split to Support Nasdaq Compliance
Premium
Company Announcements
Biodexa Pharmaceuticals Announces Reverse ADR Split to Support Nasdaq Compliance
27d ago
Biodexa Pharmaceuticals announces one-for-five reverse ADR split
Premium
The Fly
Biodexa Pharmaceuticals announces one-for-five reverse ADR split
28d ago
Biodexa Pharmaceuticals Promotes Fiona Sharp to CFO and Board Director
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Promotes Fiona Sharp to CFO and Board Director
3M ago
Biodexa Pharmaceuticals promotes Fiona Sharp to CFO, secretary
Premium
The Fly
Biodexa Pharmaceuticals promotes Fiona Sharp to CFO, secretary
3M ago
Biodexa Pharmaceuticals Prices $10 Million U.S. Public Offering to Fund Pipeline
Premium
Company Announcements
Biodexa Pharmaceuticals Prices $10 Million U.S. Public Offering to Fund Pipeline
4M ago
Biodexa Pharmaceuticals activates first European Site for Phase 3 Serenta trial
PremiumThe FlyBiodexa Pharmaceuticals activates first European Site for Phase 3 Serenta trial
5M ago
Biodexa Pharmaceuticals files to sell 3.38M units
Premium
The Fly
Biodexa Pharmaceuticals files to sell 3.38M units
5M ago
Biodexa Pharmaceuticals’ Phase 3 Serenta Trial Approved in Europe
Premium
Company Announcements
Biodexa Pharmaceuticals’ Phase 3 Serenta Trial Approved in Europe
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100